Aflazin capsules 200 mg blister No. 30

Instructions for Aflazin capsules 200 mg blister No. 30

Composition

active ingredient: 1 capsule contains 200 mg of hibiscus dry extract (hibisci extractum siccum);

excipients: lactose monohydrate, povidone;

composition of the hard gelatin capsule: gelatin, titanium dioxide (E 171), tartrazine (E 102), amaranth (E 123), erythrosine (E 127), patent blue V (E 131).

Dosage form

Capsules.

Main physicochemical properties: hard gelatin capsules with a burgundy cap and body, containing a purple-violet powder with white inclusions. The presence of compressed columns or lumps that disintegrate when pressed is allowed.

Pharmacotherapeutic group

Drugs used in urology. ATX code G04B X.

Pharmacological properties

Pharmacodynamics

The patented hibiscus extract is a source of organic acids (citric, oxysuccinic, pyrocatechin, hibiscus), vitamins, polysaccharides, bioflavonoids, which determine the bacteriostatic effect of the drug Aflazin® against most pathogens of urinary tract infections (Staphylococcus spp., Streptococcus spp., Enterococcus faecalis, Escherichia coli, Enterobacter spp. Candida spp.). It has anti-inflammatory, anti-edematous properties, exhibits an anti-adhesive effect, which prevents the adhesion (sticking) of microorganisms to the walls of the urinary tract, their development and reproduction. Prevents the development of dysuric phenomena.

Pharmacokinetics

Didn't study.

Indication

As part of complex therapy for acute and chronic infections of the bladder (cystitis) and kidneys (pyelonephritis), for asymptomatic bacteriuria, including in pregnant women.

Chronic non-infectious kidney diseases (glomerulonephritis, interstitial nephritis), prevention of urinary tract infections, including after instrumental interventions (endoscopic, X-ray and gynecological examinations).

Prevention of urinary stone formation, including after their removal.

Contraindication

Individual sensitivity to any of the components of the drug.

Interaction with other medicinal products and other types of interactions

Clinically significant drug interactions with other drugs have not been established. Aflazin® can be used in combination with antibiotics and other antimicrobial agents.

Application features

Since the medicinal product contains lactose, it should not be used in patients with rare hereditary forms of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption syndrome.

Ability to influence reaction speed when driving vehicles or other mechanisms

No effect.

Use during pregnancy or breastfeeding

The use of the drug in the first trimester of pregnancy is possible only on doctor's prescription. The use of the drug during pregnancy starting from the second trimester, as well as during breastfeeding, does not require additional consultation with a doctor.

Method of administration and doses

Adults and children over 12 years of age should take 1 capsule 2 times a day, regardless of meals. Children from 6 to 12 years of age - 1 capsule 1 time a day. The duration of use is determined by the doctor individually depending on the severity of the disease. The recommended duration of use for acute inflammation of the urinary tract and exacerbation of chronic diseases is 4–6 weeks. The recommended course of use for preventive purposes is 2–4 weeks.

Children

The drug can be used in children aged 6 years and over.

Overdose

Cases of drug poisoning due to overdose are unknown.

Adverse reactions

Allergic reactions to the components of the drug are possible.

Expiration date

3 years.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 ° C. Keep out of the reach of children.

Packaging

10 capsules in a blister, 3 blisters in a package.

Vacation category

Without a prescription.

Producer

LLC "VALARTIN PHARMA".

Location of the manufacturer and its business address

Ukraine, 08135, Kyiv region, Kyiv-Svyatoshynskyi district, Chaykyi village, Hrushevskoho str., 60.